CRP and cancer: In recent studies, the concept of the involvement of systemic inflammation in cancer progression and metastasis has been postulated.5, 6 Specifically, elevated pre‐operative CRP as marker of systemic inflammatory response has been found to be associated with decreased overall survival in osteosarcoma, chordoma, and soft tissue sarcoma.5, 7, 8, 9